Гистология малого материала различной локализации (кол-во блоковот 1 до 2-х)

Histologic examination of surgical or biopsy material (Group 3 histopathology) is used to establish or corroborate the working diagnosis and to document disease-related complications. By defining the nature and anatomic spread of a pathologic process, it enables morphologic diagnosis of malignant tumors and assists in the differential diagnosis of focal lesions in solid organs. The study also supports final diagnostic classification across oncologic, autoimmune, and infectious–inflammatory conditions, informing prognosis estimation and subsequent treatment planning. Synonyms encountered in practice include histopathology and pathomorphologic examination of resection specimens.

Preoperative assessment does not always delineate the true margins of a tumor, and even intraoperative inspection may fail to define depth of invasion or metastatic spread. Microscopic examination of stained tissue sections provides direct verification of the pathologic process, its stage, and extent, including the presence of metastases. Correlation of these findings with the clinical impression helps determine concordance between clinical and histologic diagnoses and guides subsequent management. In routine practice, multiple sections are prepared from the operative specimen, stained to highlight cellular and tissue architecture for light microscopy, mounted on glass slides, and reviewed. The examination assesses tissue structure, the magnitude of pathologic change, and cellular composition to determine cell type, degree of differentiation, and abnormal proliferation. These features underpin diagnosis of precancerous changes, primary and metastatic malignancy, and the assessment of tumor aggressiveness. Histology also evaluates the severity of inflammation and supports differentiation of acute versus chronic inflammatory processes. In selected cases, patterns consistent with specific chronic inflammation can be recognized, including autoimmune injury, tuberculosis, and sarcoidosis. When integrated with noninvasive findings, histologic results confirm suspected diagnoses and add detail on disease burden and course that is relevant for prognosis and treatment planning.